Clemedi Update Q3 2021

Clemedi Update Q3 2021

Business Development

We have been selected by Swissnex to join the India Market Entry camp. Our team will travel to India to strengthen its market entry strategy for this important market.

We are also negotiating OEM agreements with our suppliers, enabling us to sell a Clemedi branded box with all reagents. You can see our current renders for what this box might look like below.

Company Development

We have new team pitcures. During a fun photoshoot we generated picture material for the core team members.
We welcome Pauline as new addition to the team. She will be supporting development in the lab and serve as liaison to the University of Berne.

Product Development

Software Development

Implemented several new features in our software to help physicians interpret our results within known reference points. For this we added a WHO curated list of resistance confering mutations as well as generated known line-probe assay blots in the user interface as seen below.

Lab Development

We kicked off documentation of all product specifications and parameters under an ISO13485 quality management system with the help of Effectum Medical.


We are closing a last addition to our first financing round to further help us reach our goals. Details will follow.